MellingMedical today announced a strategic partnership with Converge Medical Technology, a leader in evidence-based solutions for chronic back and neck pain. The collaboration will bring Converge's innovative MedX Home Lumbar Extension Device, AXIS Cervical Strengthening Device, and digital therapeutic solutions to federal healthcare facilities nationwide. MellingMedical will leverage its extensive experience in federal contracting and status as an SBA-Verified Service-Disabled Veteran-Ow

Sentact, a leader in healthcare technology, analytics, and services reimagining the path to exceptional care, today announced it has acquired Performance Health Partners (PHP), the #1 Best-in-KLAS provider of safety event / incident management software, along with the Vizient® Patient Safety Organization (PSO), one of the nation’s largest and longest running PSOs. Together, these acquisitions broaden Sentact’s patient safety portfolio and represent two critical pieces in Senta

Companion Spine, the French-American specialist in surgeon innovated spine implant surgery, announced that the U.S. Food and Drug Administration (the “FDA”) has approved the DIAM™ Spinal Stabilization System (P240043). DIAM™ Spinal Stabilization System is the first posterior motion-preserving device approved in the U.S. for the treatment of moderate to severe primary low back pain secondary to DDD at a single lumbar level (L2–L5) in patients who remain symptomati

Rapid Medical™, a leading developer of active endovascular devices, announces the completion of patient enrollment in the DISTALS Trial, a multicenter randomized study assessing the TIGERTRIEVER 13™ device in patients with distal medium vessel occlusions (DMVO) in acute ischemic stroke. “DMVO strokes represent up to 40% of ischemic strokes and can cause significant disability, yet their treatment has remained uncertain. Recent neutral results from ESCAPE-MEVO and D

l conduct a clinical study to assess the safety and effectiveness of using nPulse technology to treat papillary thyroid microcarcinoma, a common cancer affecting hundreds of thousands of US patients. The trial is planned to commence early in 2026. The study will be conducted at two sites and is planned to enroll 30 subjects. Under an existing material transfer agreement, preclinical studies with MD Anderson researchers are ongoing to assess the effect of nsPFA energy on anaplastic thyroid car

MedeAnalytics, an industry pioneer in AI-powered enterprise healthcare intelligence, analytics, and data management, and Basys.ai, an innovation leader in agentic AI for healthcare, today announced a strategic partnership designed to accelerate decision-making, reduce cost, and improve utilization management performance for all payer lines of business. MedeAnalytics brings its broad, established healthcare footprint and intelligent analytics that easily surface insights and drive ac

Abbott today announced that Lingo, an over-the-counter continuous glucose monitor (CGM) and app, is now available for Android devices. Already available for Apple iOS devices, this expansion gives millions more people access to real-time glucose data, empowering informed choices that help support better energy, sleep, focus and overall well-being.i ii iii Lingo is for individuals 18 years of age or older and not on insulin who want to make informed decisions about their health. By s

Lightbeam Health Solutions, the proven, AI-enabled solutions and services leader in population health management, today announced its acquisition of Syntax Health, an enterprise SaaS platform that streamlines contract modeling, incentive design, and payer-provider alignment. The addition of Syntax’s capabilities strengthens Lightbeam’s ability to support healthcare organizations navigating complex incentive structures and contract modeling while advancing more collaborative, data-

University of Rochester Medical Center and GE HealthCare announce a Care Alliance to build advanced capabilities across URMC’s footprint in upstate New York, including a center of excellence in its Imaging Sciences department, the addition of diagnostic tracer production for molecular imaging applications, and the standardization of patient monitoring across the entire UR Medicine health system. The newly formed Care Alliance spans seven years and comes as an expansion of a lo

Eko Health, a leader in AI-powered cardiac and pulmonary care, announced that the Centers for Medicare & Medicaid Services (CMS) has finalized national payment for its SENSORA® platform under the Outpatient Prospective Payment System (OPPS). The decision grants payment for SENSORA exams performed in outpatient settings, ensuring hospitals and health systems can receive reimbursement for AI-enabled cardiac detection delivered at the point of care. The finalized rule establish